HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

John J V McMurray Selected Research

valsartan (Vals)

3/2015Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances.
3/2015Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial.
11/2014Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
6/2014Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
2/2014Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
11/2013Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
9/2013Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
3/2013Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.
10/2012The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
5/2012Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


John J V McMurray Research Topics

Disease

193Heart Failure
12/2015 - 01/2002
55Myocardial Infarction
12/2015 - 11/2003
36Stroke (Strokes)
12/2015 - 06/2004
27Atrial Fibrillation
12/2015 - 03/2005
18Systolic Heart Failure
03/2015 - 11/2007
15Anemia
09/2015 - 12/2004
13Kidney Diseases (Kidney Disease)
09/2015 - 03/2005
12Hypotension (Low Blood Pressure)
10/2015 - 09/2003
12Hypertension (High Blood Pressure)
10/2015 - 06/2004
10Diabetes Mellitus
04/2015 - 09/2004
10Left Ventricular Dysfunction
02/2011 - 11/2003
9Hyperkalemia
09/2014 - 10/2004
9Hemorrhage
01/2014 - 05/2008
9Embolism (Embolus)
01/2014 - 03/2005
8Cardiovascular Diseases (Cardiovascular Disease)
04/2014 - 09/2004
8Type 2 Diabetes Mellitus (MODY)
11/2013 - 03/2005
7Sudden Death
01/2015 - 10/2004
6Acute Coronary Syndrome
12/2015 - 05/2008
6Chronic Kidney Failure (Chronic Renal Failure)
09/2015 - 05/2009
6Dyspnea (Shortness of Breath)
08/2015 - 11/2007
5Inflammation
05/2013 - 12/2009
5Heart Arrest (Cardiac Arrest)
12/2012 - 09/2004
4Unstable Angina
12/2015 - 10/2005
4Coronary Disease (Coronary Heart Disease)
10/2015 - 06/2004
4Fatigue
04/2014 - 11/2009
3Body Weight (Weight, Body)
01/2015 - 04/2007
3Death (Near-Death Experience)
01/2014 - 05/2008
3Chronic Obstructive Pulmonary Disease (COPD)
05/2013 - 03/2009
3Proteinuria
02/2013 - 11/2011
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2013 - 11/2009
2Pancreatitis
12/2015 - 08/2012
2Coronary Artery Disease (Coronary Atherosclerosis)
07/2015 - 04/2007
2Venous Thromboembolism
03/2015 - 09/2013
2Angina Pectoris
12/2014 - 12/2012
2Hypertrophy
12/2014 - 09/2008
2Cough
09/2014 - 11/2003
2Ischemia
06/2014 - 02/2011
2Intermittent Claudication
01/2014 - 07/2010
2Heart Diseases (Heart Disease)
06/2013 - 02/2011

Drug/Important Bio-Agent (IBA)

48candesartanIBA
09/2015 - 09/2003
35valsartan (Vals)FDA Link
03/2015 - 11/2003
29Brain Natriuretic Peptide (Natrecor)FDA Link
08/2015 - 04/2007
23rosuvastatin (Crestor)FDA Link
12/2015 - 11/2007
22AngiotensinsIBA
10/2015 - 09/2004
17darbepoetin alfa (Aranesp)FDA Link
09/2015 - 03/2005
16Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2015 - 09/2003
16CreatinineIBA
09/2015 - 09/2004
14Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2015 - 01/2002
13eplerenone (Inspra)FDA LinkGeneric
11/2015 - 06/2009
13Neprilysin (Neutral Endopeptidase)IBA
10/2015 - 10/2012
13pro-brain natriuretic peptide (1-76)IBA
08/2015 - 03/2009
12Hemoglobins (Hemoglobin)IBA
08/2015 - 02/2006
113- (1- biphenyl- 4- ylmethyl- 3- ethoxycarbonyl- 1- butylcarbamoyl)propionate- 3'- methyl- 2'- (pentanoyl(2'- (tetrazol- 5- ylate)biphenyl- 4'- ylmethyl)amino)butyrateIBA
10/2015 - 10/2012
11apixabanIBA
02/2015 - 03/2010
10irbesartanFDA LinkGeneric
09/2015 - 02/2008
10Warfarin (Coumadin)FDA LinkGeneric
02/2014 - 03/2005
9aliskirenFDA Link
10/2015 - 05/2008
9C-Reactive ProteinIBA
08/2015 - 12/2009
9Glucose (Dextrose)FDA LinkGeneric
03/2015 - 06/2009
9Angiotensin Receptor AntagonistsIBA
05/2013 - 09/2003
8Biological Markers (Surrogate Marker)IBA
02/2015 - 07/2007
8Captopril (Capoten)FDA LinkGeneric
07/2009 - 11/2003
7EnalaprilFDA LinkGeneric
08/2015 - 01/2011
7AldosteroneIBA
11/2014 - 10/2004
7ReninIBA
12/2012 - 05/2008
6Troponin T (T, Troponin)IBA
11/2014 - 10/2011
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2014 - 01/2002
5Carbon MonoxideIBA
10/2015 - 12/2008
5nateglinide (Starlix)FDA LinkGeneric
03/2015 - 04/2010
5rosiglitazone (Avandia)FDA Link
06/2011 - 04/2007
4Insulin (Novolin)FDA Link
04/2015 - 09/2004
4Natriuretic PeptidesIBA
01/2015 - 03/2009
4Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2014 - 07/2011
4Digoxin (Digitek)FDA LinkGeneric
08/2013 - 05/2005
3Troponin IIBA
02/2015 - 11/2012
3TroponinIBA
02/2015 - 11/2012
3LDL CholesterolIBA
01/2015 - 09/2012
3Trinitrotoluene (TNT)IBA
11/2014 - 11/2011
3PotassiumIBA
10/2013 - 11/2007
3Galectin 3 (LGALS3)IBA
05/2013 - 09/2012
3Interleukin-6 (Interleukin 6)IBA
03/2013 - 01/2011
3ErythropoietinFDA Link
02/2011 - 02/2007
3Bisoprolol (Concor)FDA LinkGeneric
02/2011 - 07/2009
3CytokinesIBA
01/2011 - 12/2004
3Endothelin-1 (Endothelin 1)IBA
01/2011 - 07/2005
3Proteins (Proteins, Gene)IBA
01/2011 - 01/2005
3tezosentanIBA
01/2011 - 07/2005
3Endothelin Receptors (Endothelin Receptor)IBA
01/2011 - 07/2005
3Spironolactone (Aldactone)FDA LinkGeneric
02/2008 - 08/2004
2ZP10A peptideIBA
12/2015 - 05/2015
2BilirubinIBA
08/2015 - 02/2009
2HDL CholesterolIBA
04/2014 - 11/2012
2Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2014 - 03/2009

Therapy/Procedure

5Resuscitation
12/2012 - 09/2004
4Intensive Care (Surgical Intensive Care)
01/2015 - 10/2008
3Patient Readmission
01/2015 - 06/2006
3Cardiac Resynchronization Therapy
02/2012 - 06/2006
2Transplantation (Transplant Recipients)
09/2015 - 12/2012
2Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
02/2014 - 08/2010
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2013 - 06/2009